Celgene Corporation, a prominent biopharmaceutical company headquartered in the United States, has established itself as a leader in the development of innovative therapies for cancer and inflammatory diseases. Founded in 1986, Celgene has achieved significant milestones, including the successful launch of groundbreaking treatments that have transformed patient care. Operating primarily in North America and Europe, Celgene focuses on areas such as oncology, immunology, and haematology. Its core products, including Revlimid and Pomalyst, are renowned for their unique mechanisms of action and efficacy in treating complex conditions. With a strong market position, Celgene has garnered recognition for its commitment to research and development, making substantial contributions to the biopharmaceutical landscape.
We don't have data for Celgene Corporation, but we can show you information about their parent organization instead.
View parent company